Investor Type | Firm |
Industries | A.I. (& Big Data) • HealthTech (& Fitness) • Impact • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) |
Stages | Seed, Series A |
Investing | United States • India • Brazil |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $34,000,000 |
Alkemi Growth Capital is an investment fund that focuses primarily on early-stage growth investing within the Indian Healthcare sector. They aim to support entrepreneurs that are characterized by vision, boldness, resilience under adversity, and a driving force to make a significant positive impact in India's Healthcare industry. With an earnest mission to enhance the health and well-being of Indian consumers, Alkemi Growth Capital strives to achieve outsized returns for their shareholders by investing in companies that can transform the landscape of consumer wellness and healthcare. Their investment strategy is tailored towards sectors like A.I. (& Big Data), HealthTech (& Fitness), Impact, Medical Devices (& Hospital Services), Healthcare (& Wellness), Consumer, and Pharmaceutical (& Medicine). Alkemi Growth Capital is actively involved in Seed and Series A funding rounds and manages assets totaling around $34 million. They entertain investment opportunities with a minimum ticket size of $100,000, a maximum of $5,000,000, and a 'sweet spot' of approximately $1,500,000. The team comprises seasoned professionals from diverse backgrounds, such as former partners from McKinsey & Co., experts from the Indian Institute of Management Ahmedabad, and AIIMS. They are also advised by a board of advisors consisting of leading industry experts and executives. Through their portfolio, Alkemi is invested in businesses that are innovating in the medical treatment and services space, as well as those offering consumer healthcare products. The fund is registered with SEBI as a Category II AIF and actively manages two funds under the Alkemi Venture Fund brands.